Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation

References

• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Del Rev, 2006;58:1688–713
   PubMed Web of Science ®Google Scholar
• Abdullah GZ, Abdulkarim MF, Chitneni M, Mutee AF, Ameer OZ, Salman IM, Noor AM. Preparation and in vitro evaluation of mebeverine HCl colon-targeted drug delivery system. Pharm Dev Technol, 2011;16(4):331–42
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhter S, Ahmad I, Rahman M, Anwar M, Jain GK, Ahmad FJ, Khar RK. Development of polysaccharide based colon targeted drug delivery system: Design and evaluation of Assam Bora rice starch based matrix tablet. Curr Drug Deliv, 2011;8:575–81
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhter S, Anwar M, Ahmad FJ. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer. Mol Pharm, 2012a;9:2986–94
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhter S, Ahmad I, Singh A, Anwar M, Shamim M, Ahmad FJ. In vitro and in vivo evaluation of Assam Bora rice starch-based bioadhesive microsphere as a drug carrier for colon targeting. Expert Opin Drug Deliv, 2012b;9:141–9
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhter S, Anwar M, Singh A, Ahmad I, Ain MR, Jain GK, Khar RK, Ahmad FJ. Feasibility of Assam Bora rice starch as a compression coat of 5-fluorouracil core tablet for colorectal cancer. Curr Drug Deliv, 2012c;9:105–10
   PubMed Web of Science ®Google Scholar
• Ahmad N, Fazal H, Abbasi BH, Anwar S, Basir A. DPPH free radical scavenging activity and phenotypic difference in hepatoprotective plant (Silybum marianum L.). Toxicol Ind Health, 2013;29(5):460–7
   PubMed Web of Science ®Google Scholar
• Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm, 2005;305:22–30
   PubMed Web of Science ®Google Scholar
• Arnhold J, Furtmuller PG, Regelsberger G, Obinger C. Redox properties of the couple compound i/native enzyme of myeloperoxidase and eosinophil peroxidase. Eur J Biochem, 2001;268:5142–8
   PubMedGoogle Scholar
• Berghoff N, Hill S, Parnell NK, Mansell J, Suchodolski JS, Steiner JM. Fecal and urinary N-methylhistamine concentrations in dogs with chronic gastrointestinal disease. Vet J, 2014;201(3):289–94
   PubMed Web of Science ®Google Scholar
• Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm, 2005;304:231–8
   PubMed Web of Science ®Google Scholar
• Cetin M, Atila A, Kadioglu Y. Formulation and In vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech, 2010;11:1250–6
   PubMed Web of Science ®Google Scholar
• Champion JA, Walker A, Mitragotri S. Role of particle size in phagocytosis of polymeric microspheres. Pharm Res, 2008;25(8):1815–21
   PubMed Web of Science ®Google Scholar
• Chen H, Zheng Y, Tian G, Tian Y, Zeng X, Liu G, Liu K, Li L, Li Z, Mei L, Huang L. Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy. Nanoscale Res Lett, 2011;6:4–10
   PubMed Web of Science ®Google Scholar
• Cho BO, Ryu HW, So Y, Jin CH, Baek JY, Park KH, Byun EH, Jeong IY. Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats. Food Chem, 2013;138(1):107–15
   PubMed Web of Science ®Google Scholar
• Choonara YE, Pillay V, Valence MK, du Toit LC, Kumar P, Khan RA, Murphy CS, Jarvis DL. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloid Surf B: Biointerf, 2011;87:243–54
   PubMed Web of Science ®Google Scholar
• Clichici S, Olteanu D, Nagy AL, Oros A, Filip A, Mircea PA. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in ccl4-treated rats. J Med Food, 2014 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Dhaneshwar S, Gautam H. Exploring novel colon-targeting antihistaminic prodrug for colitis. J Physiol Pharmacol, 2012;63(4):327–37
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Palmen MJHJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 Cytokines. Clin Exp Immunol, 1998;114:385–91
   PubMed Web of Science ®Google Scholar
• Elkhodairy KA, Elsaghir HA, Al-Subayiel AM. Formulation of indomethacin colon targeted delivery systems using polysaccharides as carriers by applying liquisolid technique. Biomed Res Int, 2014;2014:704362
   PubMedGoogle Scholar
• Fonte P, Soares S, Costa A, Andrade JC, Seabra V, Reis S, Sarmento B. Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying. Biomaterials, 2012;2:329–39
   PubMedGoogle Scholar
• Gonzalez M, Rieumont J, Dupeyron D, Perdomo I, Fernandez E, Abdón L, Castaño VM. Nanoencapsulation of acetyl salicylic acid within enteric polymer nanopaticles. Rev Adv Mater Sci, 2008;17:71–5
   Web of Science ®Google Scholar
• Goycoolea FM, El Gueddari NE, Remuñán-López C, et al. Effect of molecular weight and degree of acetylation on the physicochemical characteristics of chitosan nanoparticles. The adsorption layer in the system: Carboxymethyl cellulose surfactants/NaCl/MnO2. J Surfact Deterg, 2012;15:513–21
   Google Scholar
• Hasan AA. Formulation and evaluation of dorzolamide hydrochloride-loaded nanoparticles as controlled release drug delivery system. Asian J Pharm, 2012;6:67–73
   Google Scholar
• Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Rel, 2003;89:151–65
   PubMed Web of Science ®Google Scholar
• Hubálek Z. Protectants used in the cryopreservation of microorganisms. Cryobiology, 2003;46:205–29
   PubMed Web of Science ®Google Scholar
• Kim BR, Seo HS, Ku JM, Kim GJ, Jeon CY, Park JH, Jang BH, Park SJ, Shin YC, Ko SG. Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells. Inflamm Res, 2013;62(11):941–50
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Schäfer U, Lehr CM. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res, 2001;18:788–93
   PubMed Web of Science ®Google Scholar
• Li YY, Cao MH, Goetz B, Chen CQ, Feng YJ, Chen CJ, Kasparek MS, Sibaev A, Storr M, Kreis ME. The dual effect of cannabinoid receptor-1 deficiency on the murine postoperative ileus. PLoS One, 2013;8(7):e67427
   PubMedGoogle Scholar
• Ma Y, Coombes AG. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: An evaluation of alginate carriers. J Biomed Mater Res A, 2014;102(9):3167–76
   PubMed Web of Science ®Google Scholar
• Mahapatra AK, Murthy PN, Samoju S, Mohapatra AK. Tiny technology proves big: A challenge at engineering, medicine and pharmaceutical sciences interface. Crit Rev Ther Drug Carrier Syst, 2014;31(1):1–47
   PubMed Web of Science ®Google Scholar
• Mandal B, Alexander KS, Riga AT. Sulfacetamide loaded Eudragit RL100 nanosuspension with potential for ocular delivery. J Pharm Pharm Sci, 2010;13:510–23
   PubMed Web of Science ®Google Scholar
• Marzano AV, Menicanti C, Crosti C, Trevisan V. Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol, 2013;148(2):185–96
   PubMed Web of Science ®Google Scholar
• Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silybinin inhibits human non-small cell lung cancer cell growth through cell cycle arrest by modulating expression and function of key cell cycle regulators. Mol Carcinog, 2010;49:247–58
   PubMed Web of Science ®Google Scholar
• Minaiyan M, Ghannadi AR, Etemad M, Mahzouni P. A study of the effects of Cydoniaoblonga Miller (Quince) on TNBS-induced ulcerative colitis in rats. Res Pharm Sci, 2012;7:103–10
   Google Scholar
• Motavallian-Naeini A, Minaiyan M, Rabbani M, Mahzuni P. Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat. EXCLI J, 2012;11:30–44
   PubMed Web of Science ®Google Scholar
• Müller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm, 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Niebel W, Walkenbach K, Béduneau A, Pellequer Y, Lamprecht A. Nanoparticle-based clodronate delivery mitigates murine experimental colitis. J Control Rel, 2012;160:659–65
   PubMed Web of Science ®Google Scholar
• Omwoyo WN, Ogutu B, Oloo F, Swai H, Kalombo L, Melariri P, Mahanga GM, Gathirwa JW. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles. Int J Nanomedicine, 2014;9:3865–74
   PubMed Web of Science ®Google Scholar
• Oz HS, Chen TS, Nagasawa H. Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model. Transl Res, 2007;150:122–9
   PubMed Web of Science ®Google Scholar
• Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage. Arch Pharm Res, 2011;34(5):767–74
   PubMed Web of Science ®Google Scholar
• Plewka A, Madej P, Plewka D, Kowalczyk A, Miskiewicz A, Wittek P, Leks T, Bilski R. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages. Folia Histochem Cytobiol, 2013;51(1):73–83
   PubMed Web of Science ®Google Scholar
• Rao PR, Viswanath RK. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol, 2007;12:179–87
   PubMedGoogle Scholar
• Romero-Pérez A, García-García E, Zavaleta-Mancera A, Ramírez-Bribiesca JE, Revilla-Vázquez A, Hernández-Calva LM, López-Arellano R, Cruz-Monterrosa RG. Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants. Vet Res Commun, 2010;34:71–9
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. Hand book of pharmaceutical excipients, 7th ed. Washington DC, USA/London UK: American Pharmaceutical Association/Pharmaceutical Press; 2012
   Google Scholar
• Sadeghi H, Hajhashemi V, Minaiyan M, Movahedian A, Talebi A. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. Eur J Pharmacol, 2011;667:396–401
   PubMed Web of Science ®Google Scholar
• Shastri PN, Ubale RV, D'Souza MJ. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles. Drug Dev Ind Pharm, 2013;39:164–75
   PubMed Web of Science ®Google Scholar
• Shirsagar SJK, Bhalekar MR, Shukla GN, Mohapatra SK. Development and evaluation of multiparticulate colon targeted drug delivery system by combine approach of pH and bacteria. Int J Pharm Tech Res, 2011;3:1139–49
   Google Scholar
• Singh M, Sasi P, Gupta VH, Rai G, Amarapurkar DN, Wangikar PP. Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model. Hum Exp Toxicol, 2012;31(8):788–97
   PubMed Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int J Pharm, 2004;274:1–33
   PubMed Web of Science ®Google Scholar
• Sklyarov AY, Panasyuk NB, Fomenko IS. Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. J Physiol Pharmacol, 2011;62(1):65–73
   PubMed Web of Science ®Google Scholar
• Sobczak M, Fabisiak A, Murawska N, Wesołowska E, Wierzbicka P, Wlazłowski M, Wójcikowska M, Zatorski H, Zwolińska M, Fichna J. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacol Rep, 2014;66(5):766–75
   PubMed Web of Science ®Google Scholar
• Talaei F, Atyabi F, Azhdarzadeh M, Dinarvand R, Saadatzadeh A. Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies. Eur J Pharm Sci, 2013;49(4):712–22
   PubMed Web of Science ®Google Scholar
• Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L. Eudragit nanoparticles containing genistein: Formulation, development, and bioavailability assessment. Int J Nanomed, 2011;6:2429–35
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 – Development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm, 2007;67:141–8
   PubMed Web of Science ®Google Scholar
• Thomas C, Gupta V, Ahsan F. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. Int J Pharm, 2009;379:41–50
   PubMed Web of Science ®Google Scholar
• Vaid M, Katiyar SK. Molecular mechanisms of inhibition of photo carcinogenesis by silymarin, a phytochemical from milk thistle (Silybummarianum L. Gaertn). Int J Oncol, 2010;36:1053–60
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Ahmadi F, Emami J, Tavakoli N, Minaiyan M, Mahzouni P, Dorkoosh F. Colon delivery of budesonide using solid dispersion in dextran for the treatment secondary prevention of Ulcerative colitis in rat. Int J Pre Med, 2010b;1:116–24
   Google Scholar
• Varshosaz J, Ahmadi F, Emami J, Tavakoli N, Minaiyan M, Mahzouni P, Dorkoosh F. Microencapsulation of budesonide with dextran by spray drying technique for colon targeted delivery: An in vitro/in vivo evaluation in induced colitis in rat. J Microencapsul, 2011b;28:62–73
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Fassihi A, Tavakoli N, Minaiyan M, Ahmadi F, Mahzouni P, Dorkoosh F. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Int J Colorect Dis, 2010a;10:1159–65
   Google Scholar
• Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P. Development of novel budesonide pellets based on CODES™ technology: In-vitro/in-vivo evaluation in induced colitis in rats. Daru, 2011a;19:107–17
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Ahmadi F, Tavakoli N, Minaiyan M, Fassihi A, Mahzouni P, Dorkoosh F. Preparation of budesonide-dextran conjugates using glutharate spacer as colon-targeted drug delivery system: In vitro/in vivo evaluation in induced ulcerative colitis. J Drug Target, 2011c;19:140–53
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F. Development and evaluation of a novel pellet based tablet system for potential colon delivery of budesonide. J Drug Deliv, 2012a;2012:905191
   Google Scholar
• Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P. Colon specific delivery of budesonide based on triple coated pellet: In vitro/in vivo evaluation. Acta Pharm, 2012b;62:341–56
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P. Pectin film coated pellets for colon-targeted delivery of budesonide: In-vitro/in-vivo evaluation in induced ulcerative colitis in rat. Iran J Pharm Res, 2012c;11:733–45
   PubMed Web of Science ®Google Scholar
• Wang K, Yuan CP, Wang W, Yang ZQ, Cui W, Mu LZ, Yue ZP, Yin XL, Hu ZM, Liu JX. Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. World J Gastroenterol, 2010;16(18):2252–9
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N, Wang T, Sun W, Li T. Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions. Chem Phys Lipids, 2011;164(2):151–7
   PubMed Web of Science ®Google Scholar
• Wolk O, Epstein S, Ioffe-Dahan V, Ben-Shabat S, Dahan A. New targeting strategies in drug therapy of inflammatory bowel disease: Mechanistic approaches and opportunities. Expert Opin Drug Deliv, 2013;10(9):1275–86
   PubMed Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. Colon-specific drug delivery: New approaches and in-vitro/in-vivo evaluation. Int J Pharm, 2002;235:1–15
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Q, Zhoua X, Zhang N. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm, 2008;352:273–9
   PubMed Web of Science ®Google Scholar
• Yuan H, Wang LL, Du YZ, You J, Hu FQ, Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloid Surface B: Biointerf, 2007;60:174–9
   PubMed Web of Science ®Google Scholar
• Yun J, Xu CT, Pan BR. Epidemiology and gene markers of ulcerative colitis in the Chinese. World J Gastroenterol, 2009;15:788–803
   PubMed Web of Science ®Google Scholar